BLRX
BioLineRx Ltd.
$3.29
+0.12 (+3.63%)
At close · Jul 2
Market Cap
$8.87B
Shares
2,610,814,390
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.29
Open$3.22
Day$3.17–3.29
52W$2.15–5.06
Avg vol 30d31K
Short int145K · 0.0% float · 7.4d
Short vol68%
Last earningsSep 30, 2025
DataJan 2020–Jul 2026
Equibles Rating
blended score · not investment advice
Overall
Buy
Technical · trend & momentum
Buy
◦
50 / 200-day cross
no cross
+
Price vs 200-day avg
+6% above
+
Price vs 50-day avg
+7% above
◦
RSI (14)
54 · neutral
−
MACD trend
negative
◦
52-week position
39% · mid-range
Sentiment · smart money
Bullish
◦
Trend (MA cross)
50d $3 › 200d $3 — 200d above 50d
◦
Institutional flow
0% holders QoQ · +2 funds added
◦
Insider flow
No net insider activity over 90 days
+
Short interest
0.01% of float · ▼ -12.9% MoM · 7.4 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
14 holders — mid 1-yr range
Fundamentals
Limited data
Not enough data for a confident read.
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
+6% above
Bullish
Price vs 50-day avg
+7% above
Bullish
RSI (14)
54 · neutral
Neutral
MACD trend
negative
Bearish
52-week position
39% · mid-range
Neutral
Market signals — smart money & positioning
Bullish · 1 of 6
Trend (MA cross)
No cross
50d $3 › 200d $3 — 200d above 50d
Institutional flow
Flat
0% holders QoQ · +2 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
0.01% of float · ▼ -12.9% MoM · 7.4 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
14 holders — mid 1-yr range
Price context
position in its 52-week range
52-wk low $2
Now $3 · 39%
52-wk high $5
vs 200-day avg +6%
vs 50-day avg +7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BLRX
this stock
BioLineRx Ltd.
|
$8.87B | +18.6% | — | — | 0.0% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Reducing
Holders
14
- % held
- 0.0%
- Net QoQ
- -41.6K sh
- Top holder
- XTX Topco Ltd
Held
Float
Short & Settlement
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BLRX | +5.3% | +0.2% | +10.2% | +5.3% | +18.6% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +3.9% | +1.4% | +2.2% | +5.6% | +9.4% |